InsidersTradesSigma
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by RAPP EDWARD J, Director. Director active across 2 companies, notably AbbVie Inc.. Aggregated, 11 disclosures have been recorded. Total volume traded: €810k. The latest transaction was filed on 6 May 2022 — Attribution. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations11 total
01,421 shares0
Common Stock, $0.01 par value
SEC:0001179110-22-002930:0·
01,474 shares0
Common Stock
SEC:0001209191-22-000914·
01,474 shares0
Common Stock
SEC:0001209191-22-000914:0·
€377,010100,000 shares@ €3.77011.46% mcap93.1% of flow
Common Stock
SEC:0001209191-21-066161·
Ideal exit: 15 Aug 2022 (T+270)
€377,010100,000 shares@ €3.77011.46% mcap46.5% of flow
Common Stock
SEC:0001209191-21-066161:0·
Ideal exit: 15 Aug 2022 (T+270)
€28,0815,000 shares@ €5.61610.11% mcap6.9% of flow
Common Stock
SEC:0001209191-21-054443·
Ideal exit: 29 May 2022 (T+270)
€28,0815,000 shares@ €5.61610.11% mcap3.5% of flow
Common Stock
SEC:0001209191-21-054443:0·
Ideal exit: 29 May 2022 (T+270)
0230,169 shares0
Common Stock
SEC:0001209191-21-053171·
0230,169 shares0
Common Stock
SEC:0001209191-21-053171:0·
01,681 shares0
Common Stock, $0.01 par value
SEC:0001179110-21-005206·
01,681 shares0
Common Stock, $0.01 par value
SEC:0001179110-21-005206:0·
11 of 11 declarations
About RAPP EDWARD J
Edward J. Rapp is a Board Member at AbbVie Inc. and Xos, Inc. He brings expertise in corporate governance and business strategy. His role involves overseeing operations and advising management on best practices in governance.
